Review article on building an adverse drug reaction reporting culture for patient safety
Abstract
Adverse Drug Reactions (ADRs) significantly threaten patient safety and healthcare quality. Developing a robust culture of ADR reporting is vital for mitigating risks and enhancing patient outcomes. This review examines the necessity of fostering a supportive ADR reporting environment, identifies common barriers to effective reporting, and proposes comprehensive strategies to create a proactive reporting culture.
Keywords:
ADR (adverse drug reaction), patient safety, workshop, training, WHO (world health organisation)DOI
https://doi.org/10.70604/ijzels.v1i1.1References
1. Zdrowia ŚO, editor. The importance of pharmacovigilance: safety monitoring of medicinal products. World Health Organization; 2002.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama. 1998 Apr 15;279(15):1200-5.
3. Sharma S, Sharma R, Devi A, Jindal S, Goyal K. A review on characteristics and analytical methods of atovaquone–a potent antimalarial agent. Journal of Applied Pharmaceutical Research. 2020 Aug 31;8(3):31-7.
4. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. The lancet. 2000 Oct 7;356(9237):1255-9.
5. Sultana J, Zaccaria C, De Lisa R, Rossi F, Capuano A, Ferrajolo C. Good pharmacovigilance practice in paediatrics: an overview of the updated European Medicines Agency Guidelines. Pediatric Drugs. 2019 Oct;21(5):317-21.
6. Cohen MR, Smetzer JL, Vaida AJ. ASHP guidelines on preventing medication errors in hospitals: advancing medication safety to the next level. American Journal of Health-System Pharmacy. 2018 Oct 1;75(19):1444-5.
7. Food US. Drug Administration 2005. Guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment.
8. World Health Organization. The importance of pharmacovigilance.
9. Sultana J, Zaccaria C, De Lisa R, Rossi F, Capuano A, Ferrajolo C. Good pharmacovigilance practice in paediatrics: an overview of the updated European Medicines Agency Guidelines. Pediatric Drugs. 2019 Oct;21(5):317-21.
10. Bahri P, Tsintis P. Pharmacovigilance‐related topics at the level of the International Conference on Harmonisation (ICH). Pharmacoepidemiology and drug safety. 2005 Jun;14(6):377-87.
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama. 1998 Apr 15;279(15):1200-5.
12. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. The lancet. 2000 Oct 7;356(9237):1255-9.
13. Food US. Drug Administration 2005. Guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment.
14. Khalid H, Ghafoor N, Anees N, Naeem A, Hayat I, Khalil M, Ummara UE, Mehar T, Ghafoor A. Emerging Infectious Diseases
Published
Abstract Display: 207 
PDF Downloads: 154 How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/lapinjournals/domains/lapinjournals.com/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
.